RECRUITING

Cervical Plexus Hydrodissection With D5W for PTSD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.

Official Title

Cervical Plexus Hydrodissection With D5W for PTSD Versus Delayed Treatment/Usual Care

Quick Facts

Study Start:2023-07-10
Study Completion:2027-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04421573

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Not involved in another study of PTSD treatment
  2. * Reliable transportation
  3. * Comfortable with computers
  4. * Tried 2 or more medications for treatment of PTSD symptoms
  5. * Tried 2 or more non-medication treatments for PTSD symptom
  6. * No known life-threatening illness
  7. * Not taking daily narcotics
  8. * Not having 3or more alcoholic drinks on an average day
  9. * No active suicidal plans
  10. * No major surgery plans
  11. * No major life stress that might interfere with completing study
  12. * Symptoms for more than 1 year
  13. * Not planning to move for next 18 months.
  14. * Living within an hour of Kelowna or Victoria, British Columbia, Portland, Oregon, Madison, Wisconsin, or Hong Kong
  15. * Wiling to provide 2 email and 2 phone contact methods
  16. * Willing to answer questions on multiple occasions over the course of a year.
  17. * Willing to be assigned to 3 months of usual care treatment
  18. * No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.
  19. * No severe needle phobia
  20. * Chronic pain ≤ 5/10
  21. * PCL-C score ≥ 50
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kenneth D Reeves, M.D.
CONTACT
9133621600
DeanReevesMD@gmail.com
Kenneth D Reeves, M.D.
CONTACT
9133621600
ReevesOffice@gmail.com

Principal Investigator

Kenneth D Reeves, M.D.
PRINCIPAL_INVESTIGATOR
Dr. Dean Reeves Clinic

Study Locations (Sites)

Hawaii Center for Regenerative Medicine
Hilo, Hawaii, 96720
United States
Paul W. Johnson, D.O., Clinic.
Portland, Oregon, 87213
United States
Northwest Regenerative Orthopedics
Tigard, Oregon, 97224
United States
Eric Phillippi M.D. Clinic
Madison, Wisconsin, 53719
United States

Collaborators and Investigators

Sponsor: Dr. Dean Reeves Clinic

  • Kenneth D Reeves, M.D., PRINCIPAL_INVESTIGATOR, Dr. Dean Reeves Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-10
Study Completion Date2027-10-01

Study Record Updates

Study Start Date2023-07-10
Study Completion Date2027-10-01

Terms related to this study

Keywords Provided by Researchers

  • Dextrose
  • Hydrodissection
  • Cervical Plexus

Additional Relevant MeSH Terms

  • PTSD